Latest Health News

Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.

HyTerra Limited has reported exceptional hydrogen and helium concentrations from its Sue Duroche 3 well in Kansas, marking a significant milestone in natural gas exploration and clean energy potential.

RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.

Lincoln Minerals’ Kookaburra Graphite Project has delivered battery-grade graphite purity exceeding 99.95%, confirming its suitability for lithium-ion battery anodes through a safer, hydrofluoric acid-free process.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Elixinol Wellness Ltd has raised $1.5 million through a mix of debt and equity to boost automation and expand its key brands, including Healthy Chef and Soul Seeds.

Nufarm Limited reported a 3% revenue increase and a 17% rise in underlying EBIT for HY25, driven by strong crop protection volumes and improved cost management. However, net debt climbed 12%, pushing leverage to 4.5 times, highlighting ongoing financial balancing acts.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.

LTR Pharma has appointed Associate Professor Darren Katz, a leading urologist and erectile dysfunction expert, to its Scientific Advisory Board, aiming to fast-track the development and commercialization of its innovative nasal spray treatments SPONTAN and ROXUS.

Nufarm Limited reported a solid half-year performance with a 3% revenue increase and a 40% jump in underlying EBIT, driven by strong crop protection sales and cost improvements. However, net debt rose 12%, reflecting investments in omega-3 production and seed technology expansion.

Catapult Group International has reported a milestone FY25, surpassing US$100 million in Annualized Contract Value and delivering a record US$8.6 million in free cash flow, underscoring its growing dominance in sports technology.